Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

Chott, A; Gisslinger, H; Thiele, J; Fritz, E; Linkesch, W; Radaszkiewicz, T; Ludwig, H.
Interferon-alpha-induced morphological changes of megakaryocytes: a histomorphometrical study on bone marrow biopsies in chronic myeloproliferative disorders with excessive thrombocytosis.
BRIT J HAEMATOL. 1990; 74(1): 10-16. Doi: 10.1111/j.1365-2141.1990.tb02531.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Co-Autor*innen der Med Uni Graz
Linkesch Werner
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Interferon(rIFN)-alpha, a successful therapeutic agent in the control of thrombocytosis, has been shown to suppress human megakaryopoiesis. We investigated bone marrow biopsies from 12 patients with thrombocytosis due to chronic myeloproliferative disorders. Prior to treatment as well as during rIFN-alpha-2c therapy, several morphometric parameters of megakaryopoiesis were evaluated. Megakaryocyte density decreased significantly in all patients, megakaryocyte size decreased in polycythaemia vera, agnogenic myeloid metaplasia, and essential thrombocythaemia, but increased in chronic myeloid leukaemia. The various changes observed during therapy indicate an inhibitory effect of rIFN-alpha-2c on megakaryopoiesis and suggest a selective influence on megakaryocytes at various stages of maturation. Increased numbers of pyknotic (bare) nuclei may reflect a shortening of megakaryocyte life-span. No remarkable changes were found in the fibre content of the bone marrow.
Find related publications in this database (using NLM MeSH Indexing)
Aged -
Biopsy -
Bone Marrow - pathology
Chronic Disease - pathology
Female - pathology
Humans - pathology
Interferon Type I, Recombinant - therapeutic use
Male - therapeutic use
Megakaryocytes - pathology
Middle Aged - pathology
Myeloproliferative Disorders - complications
Thrombocytosis - etiology

© Med Uni Graz Impressum